Trinity Biotech Plc (TRIB)
0.61
+0.01
(+1.33%)
USD |
NASDAQ |
May 07, 16:00
0.61
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Research and Development Expense (Annual) : 3.640M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amarin Corp. Plc | 16.82M |
| Cellectis SA | 75.08M |
| Akari Therapeutics Plc | 2.822M |
| Biodexa Pharmaceuticals Plc | 5.026M |
| NuCana Plc | 16.79M |